New original combined antiglaucoma agent proxocarpin:experimental studying

Iagorashvili  M. Т. and Yermakova  V. Н.

Moscow Helmholtz Research Institute of Eye Diseases, Russia

Purpose: to study the effect of proxocarpin (hybrid  β 1,2 – α 1 - adrenergic-blocker  proxodolol 1 % and  pilocarpin  1 %) on intraocular pressure (IOP), outflow  facility  and  pupil  size in rabbits.

Methods: electronic tonography and  pupillometry were used on 32 grey  Shinshilla  rabbits.

Results: proxocarpin is well endured in rabbits; proxocarpin has more marked  and  long  hypotensive  effect, than each agent: IOP  lowering efficacy of proxocarpin by increasing of outflow facility, while proxodolol hypotensive effect is explained by depression of aqueous humor production.  

Discussion: the combined agent proxocarpin caused an additional hypotensive  effect. Proxocarpine miotic effect is a little bit weaker than with  instillation of  pilocarpine.

Conclusions: due to the experimental data and positive results of the  clinical useing of combined instillation β adrenergic-blocker  and cholinomimetics  it’s possible to used  proxocarpin to clinical study as IOP lowering means.